SARILUMAB FOR THE TREATMENT OF MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS: RESULTS OF A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, INTERNATIONAL STUDY

被引：0
|
作者：
Huizinga, T. W. [1 ]
Kivitz, A. J. [2 ]
Rell-Bakalarska, M. [3 ]
Fleischmann, R. M. [4 ]
Jasson, M. [5 ]
Radin, A. R. [6 ]
Genovese, M. C. [7 ]
机构：
[1] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands
[2] Altoona Ctr Clin Res, Dept Rheumatol, Duncansville, PA USA
[3] Rheumatol & Osteoporosis Outpatient Clin, Warsaw, Poland
[4] 1 Metroplex Clin Res Ctr, Dallas, TX USA
[5] Sanofi, Paris, France
[6] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA
[7] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 71卷
关键词：
D O I：
10.1136/annrheumdis-2012-eular.1706
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：60 / 60
页数：1
相关论文
共 50 条
  • [1] Sarilumab for the Treatment of Moderate-to-Severe Rheumatoid Arthritis: Results of a Phase 2, Randomized, Double-Blind, Placebo-Controlled, International Study
    Genovese, Mark C.
    Kivitz, Alan J.
    Simon Campos, J. Abraham
    Rell-Bakalarska, Maria
    Fleischmann, Roy M.
    Jasson, Martine
    Radin, Allen R.
    Huang, Xiaohong
    Huizinga, Tom W. J.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (12): : 4041 - 4042
  • [2] EFFECTS OF SARILUMAB PLUS MTX ON CLINICAL, RADIOGRAPHIC, AND FUNCTIONAL ENDPOINTS IN PATIENTS WITH MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS: RESULTS OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, INTERNATIONAL STUDY
    Genovese, M.
    Fleischmann, R. M.
    Kivitz, A. J.
    Rell-Bakalarska, M.
    Martincova, R.
    Fiore, S.
    Rohane, P.
    van Hoogstraten, H.
    Fan, C.
    van Adelsberg, J.
    Weinstein, S.
    Graham, N.
    Stahl, N.
    Yancopoulos, G.
    Huizinga, T. W.
    van der Heijde, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 70 - 70
  • [3] SARILUMAB FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS: RESULTS OF A PHASE 2, RANDOMIZED. DOUBLE-BLIND, PLACEBO-CONTROLLED, INTERNATIONAL STUDY (ALIGN)
    Sieper, J.
    Inman, R. D.
    Badalamenti, S.
    Radin, A.
    Braun, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 111 - 112
  • [4] Apremilast for the treatment of moderate-to-severe palmoplantar psoriasis: results from a double-blind, placebo-controlled, randomized study
    Bissonnette, R.
    Haydey, R.
    Rosoph, L. A.
    Lynde, C. W.
    Bukhalo, M.
    Fowler, J. F.
    Delorme, I.
    Gagne-Henley, A.
    Gooderham, M.
    Poulin, Y.
    Barber, K.
    Jenkin, P.
    Landells, I.
    Pariser, D. M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (03) : 403 - 410
  • [5] Risankizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
    Stephen K. Tyring
    Phoebe Rich
    Yayoi Tada
    Stefan Beeck
    Izabella Messina
    Jie Liu
    Xiaohong Huang
    Stephen Shumack
    Dermatology and Therapy, 2023, 13 : 595 - 608
  • [6] Risankizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
    Tyring, Stephen K. K.
    Rich, Phoebe
    Tada, Yayoi
    Beeck, Stefan
    Messina, Izabella
    Liu, Jie
    Huang, Xiaohong
    Shumack, Stephen
    DERMATOLOGY AND THERAPY, 2023, 13 (02) : 595 - 608
  • [7] Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma
    Del Rosario, Eunice
    Florez-Pollack, Stephanie
    Zapata, Lucio, Jr.
    Hernandez, Katia
    Tovar-Garza, Andrea
    Rodrigues, Michelle
    Hynan, Linda S.
    Pandya, Amit G.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (02) : 363 - 369
  • [8] Treatment of rheumatoid arthritis with ornidazole: a randomized, double-blind, placebo-controlled study
    Ogrendik, Mesut
    RHEUMATOLOGY INTERNATIONAL, 2006, 26 (12) : 1132 - 1137
  • [9] Treatment of rheumatoid arthritis with ornidazole: a randomized, double-blind, placebo-controlled study
    Mesut Ogrendik
    Rheumatology International, 2006, 26 : 1132 - 1137
  • [10] A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn's Disease
    Targan, Stephan R.
    Feagan, Brian
    Vermeire, Severine
    Panaccione, Remo
    Melmed, Gil Y.
    Landers, Carol
    Li, Dalin
    Russell, Chris
    Newmark, Richard
    Zhang, Nan
    Chon, Yun
    Hsu, Yi-Hsiang
    Lin, Shao-Lee
    Klekotka, Paul
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (11): : 1599 - 1607
12345